Complete Recovery of Oxysterol 7α-Hydroxylase Deficiency by Living Donor Transplantation in a 4-Month-Old Infant: the First Korean Case Report and Literature Review.
Jeana HongSeak Hee OhHan Wook YooHiroshi NittonoAkihiko KimuraKyung Mo KimPublished in: Journal of Korean medical science (2018)
Oxysterol 7α-hydroxylase deficiency is a very rare liver disease categorized as inborn errors of bile acid synthesis, caused by CYP7B1 mutations. As it may cause rapid progression to end-stage liver disease even in early infancy, a high index of suspicion is required to prevent fatal outcomes. We describe the case of a 3-month-old boy with progressive cholestatic hepatitis and severe hepatic fibrosis. After excluding other etiologies for his early liver failure, we found that he had profuse urinary excretion of 3β-monohydroxy-Δ5-bile acid derivatives by gas chromatography/mass spectrometry analysis with dried urine spots on filter paper. He was confirmed to have a compound heterozygous mutation (p.Arg388Ter and p.Tyr469IlefsX5) of the CYP7B1 gene. After undergoing liver transplantation (LT) from his mother at 4 months of age, his deteriorated liver function completely normalized, and he had normal growth and development until the current follow-up at 33 months of age. We report the first Korean case of oxysterol 7α-hydroxylase deficiency in the youngest infant reported to undergo successful living donor LT to date.
Keyphrases
- liver failure
- gas chromatography mass spectrometry
- early onset
- replacement therapy
- hepatitis b virus
- multiple sclerosis
- liver injury
- liver fibrosis
- genome wide
- drug induced
- weight gain
- metabolic syndrome
- patient safety
- type diabetes
- stem cells
- adipose tissue
- adverse drug
- dna methylation
- cell therapy
- skeletal muscle
- quantum dots